News

From February 5th to 8th, 2024, the 23rd Middle East International Exhibition of Laboratory Equipment (Medlab Middle East) was held at the Dubai World Trade Center. This exhibition brought together more than 900 medical companies from over 40 countries and regions around the world, attracting more than 30,000 professionals to participate. It is an ideal platform to showcase the latest technologies and innovative achievements in the field of medical experiments.

Autobio showcased its strategic products and series of solutions in immunology, microbiology, and molecular biology, including the automatic luminescence immunoassay analyzer AutoLumo A1860 and the automated mass spectrometry microbial  detection system Autof MS1000. These products attracted the attention of many visitors. The international business team of Autobio conducted in-depth discussions with visitors and actively promoted the company's latest technological achievements.

On the first day of the exhibition, Autobio newly launched its automatic luminescence immunoassay analyzer AutoLumo A6200 and the automatic coagulation analyzers Ci-120x and Ci-310 to the global market for the first time. The AutoLumo A6200 can be expanded into the Autolas X-1 series TLA solution, aiming to provide high-throughput and high-precision testing services. The automatic coagulation analyzer Ci-310 is mainly targeted at large and medium-sized inspection laboratories, while the automatic coagulation analyzer Ci-120x is mainly targeted at small and medium-sized inspection laboratories. These two instruments aim to meet the diverse clinical needs for coagulation testing with more accurate test results and superior comprehensive efficiency.

During the exhibition, Autobio held its 8th International Distributor Conference. At the meeting, Mr. Fu Guangyu, the company's executive vice president, expressed the great gratitude to international partners, showcased Autobio' achievements in 2023, and looked forward to a prosperous future for overseas markets. He said that Autobio will continue to accelerate its global market strategy, aiming to provide overseas users with more, better, and more internationally market-oriented product solutions and marketing plans. The company will work hand in hand with global partners to share development results and achieve win-win cooperation!

Autobio adheres to the mission of “Committed to the promotion and advancement of medical laboratory technology, dedicated to serving human healthcare.” We will continue to increase investment in technological innovation, enrich our product line, actively expand international markets, and provide more comprehensive and high-quality products and services to global customers.